AMDG Distributors (New Distributors Still Required)
 
 
The market opportunity for the VariaCardio® TF5
The world-wide marketplace for sales of the VariaCardio® TF5 is immense. The opportunities for sales range from individual physicians, cardiologists and/or diabetologists/endocrinologists to hospitals, screening clinics, alternative medicine facilities such as chiropractors and acupuncturists, weight loss clinics and massage therapists, universities and colleges, health and fitness outlets, professional sports teams, veterinary practices and even the armed services.
 
Regulatory Approvals
AMDG has already funded the achievement of the European CE mark for the TF5 and is well advanced in preparing the necessary information to obtain FDA 510(k) approval to market the TF5 in the USA. Our FDA submission is due to be completed by the end of September 2002 and we plan sales to commence in the USA in May 2003. In addition, product registration and regulatory approvals are currently being prepared for Japan.
 
Heart Rate Variability (“HRV”) Clinical Advocacy
Numerous scientific studies throughout the world have shown that the use of Heart Rate Variability monitors can detect the onset of cardiovascular disturbance prior to any signs of damage to the heart.

The VariaCardio® TF5 is the first instrument in the world to offer doctors an easy and fast telemetric analysis of Heart Rate Variability. The high sampling frequency and advanced statistical analysis ensures accurate results in only 15 minutes, unlike existing other methods which require tests lasting 24 hours and are vulnerable to inaccuracies. In addition, remote screening and diagnosis is possible through the use of sophisticated software that requires minimum training.
 
Existing Medical Partners and Distributors
In the UK AMDG is working in close collaboration with both Dr Jim Nolan’s hospital (Stoke City General) and Dr. Mike Chester (at the Cardiac-Thoracic Centre, Liverpool and the National Refractory Angina Centre, Liverpool). A 'two centre' study to further refine and validate the VariaCardio® TF5 for cardiac risk stratification.

AMDG has appointed Beaver Medical as a distributor in the UK to represent the VariaCardio® TF5 in the NHS and Private Hospital sector and will shortly sign a distribution agreement with EU-Medical to represent the VariaCardio® TF5 in Germany.
 
Contact us
We are looking for additional Distributors to help us to achieve our aim of establishing world markets initially with the VariaCardio® TF5 system and related services, in order to become a market leader in the supply of innovative medical products uniquely positioned in the early detection and diagnostic sector identifying issues of failing health,

Contact either Paul Highett-Smith Chairman or Dr Malcolm Ellis Managing Director.
 
 
All material contained within this website is copyrighted to Advanced Medical Diagnostic Group Limited.
VariaCardio® and VariaPulse are registered trademarks of AMDG Ltd. This product is protected by patents owned by AMDG Ltd.

Manufactured for AMDG by MIE Medical Research Ltd (an ISO13488 accredited company). AMDG and MIE Research Ltd reserve the right to amend specifications without notice in accordance to their policy of continual product improvement.
 
© 2001-5 Advanced Medical Diagnostics Group Ltd. All Rights Reserved.
 

AMDG Ltd, 6 Wortley Moor Road, Leeds, LS12 4JF
Tel: +44 (0) 113 279 1010 Fax: +44 (0) 113 231 0820